Hypoxia Regulates CD44 and Its Variant Isoforms through HIF-1α in Triple Negative Breast Cancer
Open Access
- 28 August 2012
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 7 (8) , e44078
Abstract
The CD44 transmembrane glycoproteins play multifaceted roles in tumor progression and metastasis. CD44 expression has also been associated with stem-like breast cancer cells. Hypoxia commonly occurs in tumors and is a major cause of radiation and chemo-resistance. Hypoxia is known to inhibit differentiation and facilitates invasion and metastasis. Here we have investigated the effect of hypoxia on CD44 and two of its isoforms in MDA-MB-231 and SUM-149 triple negative human breast cancer cells and MDA-MB-231 tumors using imaging and molecular characterization. The roles of hypoxia and hypoxia inducible factor (HIF) in regulating the expression of CD44 and its variant isoforms (CD44v6, CD44v7/8) were investigated in human breast cancer cells, by quantitative real-time polymerase chain reaction (qRT-PCR) to determine mRNA levels, and fluorescence associated cell sorting (FACS) to determine cell surface expression of CD44, under normoxic and hypoxic conditions. In vivo imaging studies with tumor xenografts derived from MDA-MD-231 cells engineered to express tdTomato red fluorescence protein under regulation of hypoxia response elements identified co-localization between hypoxic fluorescent regions and increased concentration of 125I-radiolabeled CD44 antibody. Our data identified HIF-1α as a regulator of CD44 that increased the number of CD44 molecules and the percentage of CD44 positive cells expressing variant exons v6 and v7/8 in breast cancer cells under hypoxic conditions. Data from these cell studies were further supported by in vivo observations that hypoxic tumor regions contained cells with a higher concentration of CD44 expression.Keywords
This publication has 40 references indexed in Scilit:
- Assessment of tumour hypoxia for prediction of response to therapy and cancer prognosisJournal of Cellular and Molecular Medicine, 2010
- CD44 crosslinking-mediated matrix metalloproteinase-9 relocation in breast tumor cells leads to enhanced metastasis.International Journal of Oncology, 2007
- Hypoxia in cancer: significance and impact on clinical outcomeCancer and Metastasis Reviews, 2007
- Heparanase, Hyaluronan, and CD44 in Cancers: A Breast Carcinoma PerspectiveCancer Research, 2006
- HIF-1 and tumour radiosensitivityBritish Journal of Cancer, 2006
- Enhanced cell surface CD44 variant (v6, v9) expression by osteopontin in breast cancer epithelial cells facilitates tumor cell migration: Novel post-transcriptional, post-translational regulationClinical & Experimental Metastasis, 2005
- Targeting HIF-1 for cancer therapyNature Reviews Cancer, 2003
- Regulation of colon carcinoma cell invasion by hypoxia-inducible factor 1.2003
- Overexpression of hypoxia-inducible factor 1alpha in common human cancers and their metastases.1999
- Expression of the Hermes-1 (CD44) and ICAM-1 (CD54) Molecule on the Surface of Thyroid Cells from Patients with Graves' DiseaseThyroid®, 1993